Author:
Abdallah Hisham,Jerling Markus
Subject
Pharmacology (medical),Pharmacology
Reference9 articles.
1. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris subjects treated with beta-blocker or diltiazem;Cocco;J Cardiovasc Pharmacol.,1992
2. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in subjects with severe chronic angina: a randomized controlled trial;Chaitman;JAMA.,2004
3. Anti-ischemic effects and long-term survival during ranolazine monotherapy in subjects with severe coronary artery disease and chronic angina: the MARISA trial;Chaitman;J Am Coll Cardiol.,2004
4. A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group;Pepine;Am J Cardiol.,1999
5. Disposition of [14C]-ranolazine in humans [abstract 98];Chu;Drug Metab Rev.,2003
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献